Adverum Biotechnologies
ADVM
ADVM
141 hedge funds and large institutions have $1.69B invested in Adverum Biotechnologies in 2020 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 60 increasing their positions, 38 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
14% more funds holding in top 10
Funds holding in top 10: 7 → 8 (+1)
12% more funds holding
Funds holding: 126 → 141 (+15)
0.07% less ownership
Funds ownership: 10.14% → 10.07% (-0.07%)
Holders
141
Holding in Top 10
8
Calls
$15.9M
Puts
$5.1M
Top Buyers
| 1 | +$25.9M | |
| 2 | +$18.1M | |
| 3 | +$15.5M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$14M |
| 5 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$11M |
Top Sellers
| 1 | -$30.4M | |
| 2 | -$27.1M | |
| 3 | -$25.9M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$16.9M |
| 5 |
Renaissance Technologies
New York
|
-$10.5M |